Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
2(66.7%)
Phase 2
1(33.3%)
3Total
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01976065Phase 1Completed

Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots

Role: lead

NCT02689713Phase 2Withdrawn

Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent

Role: lead

NCT01805388Phase 1Withdrawn

Comparison of Tissue in Regenerative Endodontic Procedures and Apexification

Role: lead

All 3 trials loaded